Reuters logo
FDA puts Celgene's multiple cancer trials on hold
2017年9月7日 / 中午12点05分 / 2 个月前

FDA puts Celgene's multiple cancer trials on hold

Sept 7 (Reuters) - Celgene Corp said on Thursday the U.S. Food and Drug Administration had placed a partial clinical hold on the company’s five trials and a full clinical hold on one trial.

The trials are testing AstraZeneca Plc’s key immunotherapy, Imfinzi, in combination with chemical agents, with or without chemotherapy, in blood cancers such as multiple myeloma, chronic lymphocytic leukaemia and lymphoma. (Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Maju Samuel)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below